Fact sheet for health care providers : Trioplex Real-Time RT- PCR Assay (Trioplex rRT-PCR) Results
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Help
Clear All

Query Builder

Query box

Help
Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Fact sheet for health care providers : Trioplex Real-Time RT- PCR Assay (Trioplex rRT-PCR) Results

  • March 17, 2016

Filetype[PDF-32.88 KB]


  • English
    • Details You May Also Like

    Details:

    • Description:
      Dear Health Care Provider:

      The U.S Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) to authorize the use of the Centers for Disease Control and Prevention’s (CDC) Trioplex Real-time RT-PCR Assay (Trioplex rRT-PCR) for the in vitro qualitative detection of Zika virus. With specified instruments, this assay tests for Zika virus, dengue virus and chikungunya virus RNA in serum and cerebrospinal fluid (CSF). The assay also tests for Zika virus in urine and amniotic fluid specimens. Testing should only be conducted on specimens from individuals meeting CDC Zika clinical and epidemiological criteria for testing in laboratories designated by the CDC: http://www.cdc.gov/zika/hc-providers/index.html.

      FDA issued this EUA based on data submitted by CDC to FDA, and on the U.S. Secretary of Health and Human Services’ (HHS) declaration that circumstances exist to justify the emergency use of in vitro diagnostic tests for the detection of Zika virus and/or diagnosis of Zika virus infection. This EUA will terminate when the HHS Secretary’s declaration terminates, unless FDA revokes it sooner.

      The information in this Fact Sheet is to inform you of the significant known and potential risks and benefits of the emergency use of the Trioplex rRT-PCR. For more information on this EUA, please see FDA’s website at (http://www.fda.gov/MedicalDevices/Safety/EmergencySituations/ucm161496.htm).

      fact-sheet-for-hcp-eua-trioplex-rt-pcr-zika.pdf

    • Subjects:
    • Document Type:
      Pamphlet (or booklet)
    • Genre:
      Fact Sheet
    • Collection(s):
    • Main Document Checksum:
    • Download URL:
    • File Type:

    Supporting Files

    • No Additional Files

    More +

    You May Also Like

    Checkout today's featured content at stacks.cdc.gov